相似文献/References:
[1]李晓光,金征宇,潘杰,等.肝动脉化疗或栓塞治疗胰腺神经内分泌肿瘤肝转移的疗效分析[J].介入放射学杂志,2010,(06):442.
LI Xiaoguang,JIN Zhengyu,PAN Jie,et al.Hepatic transarterial chemoperfusion and chemoembolization for the treatment of liver metastases from pancreatic neuroendocrine tumors：a therapeutic analysis[J].journal interventional radiology,2010,(01):442.
[2]陈伟敏,罗佐权.肝癌肝动脉灌注化疗与静脉输注硫代硫酸钠的“双路”疗法18例报告[J].介入放射学杂志,1992,(01):26.
[3]秦伟,巫北海.5-FUDR经肝动脉灌注致硬化性胆管炎[J].介入放射学杂志,1996,(01):59.
[4]中国抗癌协会肿瘤介入学专业委员会,中国抗癌协会肿瘤介入学专业委员会化疗与免疫治疗分委会.改良式经皮肝动脉化疗药盒植入技术中国专家共识（2022版）[J].介入放射学杂志,2022,31(07):633.
Professional Committee of Oncology Intervention,China Anti-Cancer Association,Chinese expert consensus on the modified implantation technique of port-catheter system for percutaneous hepatic arterial infusion chemotherapy（version 2022）[J].journal interventional radiology,2022,31(01):633.
[5]徐永康,付舒敏,李 丹,等.肝动脉灌注化疗联合系统治疗在原发性肝癌中的研究进展[J].介入放射学杂志,2023,32(01):94.
XU Yongkang,FU Shumin,LI Dan,et al.Research progress in hepatic arterial infusion chemotherapy combined with systemic therapy for the treatment of primary hepatocellular carcinoma[J].journal interventional radiology,2023,32(01):94.